Rehabilitation Bioengineering Group · IIT Madras
Research Patents
A record of patented innovations in biomedical engineering, tissue engineering, cardiac diagnostics, and surgical devices from the RBG Lab.
All Patents
1
A Bioreactor for Tissue Engineering
S. Guhathakurta and V. Balasubramanian
Patent Granted
Technology Transferred
Royalty Earning
STEM Impact Award 2022
Indian Patent Application Number
2062 / CHE / 2013
Granted Patent Number
Grant No. 510399
Technology Transfer
Technology Transferred to M/s Synchromax Biotech Pvt Limited lead to a commercial product SynchroScaff that is currently in production.
Royalty Details
Receive 0.2 plus 5% Royalty on Sales.
Award Recognition
Won STEM IMPACT Awards 2022 with Dr. Soma in recognition for the development and successful tech transfer of an indigenous biological scaffold innovation, which led to the formation of the startup SynkroMax.
Real-World Impact
Facilitates tissue repair and regeneration, leading to the formation of the startup SynkroMax. This technology supports affordable and accessible healthcare solutions for wound healing and reconstructive surgery in India.
2
Polymeric Biomaterial for Dental Applications
V. S. Anand and V. Balasubramanian
Patent Granted in 2023
Indian Patent Application Number
2709 / CHE / 2013
Granted Patent Number
Grant No. 343192
Granted in 2023
Granted in 2023
Real-World Impact
Provides an affordable, locally developed dental restoration material, improving access to quality dental care and reducing dependence on imports.
3
Electrophysiological Monitoring of the Heart Using Dry Electrodes on Non-Traditional, Non-Bony Regions of the Chest
V. Balasubramanian, S. Guhathakurta and S. Robert Rajkumar
Patent Granted in 2023
Indian Patent Application Number
940 / CHE / 2014
Granted Patent Number
Grant No. 434703
Granted in 2023
Granted in 2023
What This Technology Does
The patented technology addresses limitations of conventional ECG systems to be used for ubiquitous measurements. This patent represents a paradigm shift in cardiac diagnostics, combining non-invasive design with advanced signal processing. Its grant underscores its novelty and potential to improve heart disease management globally.
4
Apparatus and System for Occluding and Opening Blood Vessel
V. Balasubramanian, V. B. Narayanamurthy and A. Parikh
Technology Transferred
Royalty Earning
Indian Patent Application Number (First)
4165 / CHE / 2015
Indian Patent Application Number (Second)
4166 / CHE / 2015
Technology Transfer
Technology Transferred to M/s Shira Biotech, a Start-up Firm with the product in current production.
Royalty Details
Receive 5% Royalty on Sales.
Real-World Impact
Provides a medical device for controlled occlusion and opening of blood vessels, improving the safety and outcomes of surgical and interventional procedures, especially in trauma and emergency care.
5
Engineered Pericardium and Derivatives for Uses in Medicine, Pharmaceuticals, Food and Cosmetics
S. Guhathakurta and V. Balasubramanian
Patent Not Granted
Indian Patent Application Number
138 / CHE / 2014
Reason Patent Was Not Granted
Patent Not Granted. Citing a publication from the lab could be used to derive the product.
What This Innovation Does
A tissue engineered indigenous pericardial patch has the property of regeneration and integration in the body and ease of handling by the surgeons.
Real-World Impact and Context
Presently India imports 100% of biological origin surgical patches which have limited versatility and are inadequate in meeting the demands. A tissue engineered indigenous pericardial patch has the property of regeneration and integration in the body and ease of handling by the surgeons. The innovation will provide cardiac patches for cardiac surgeries at very low cost as compared to current imported patches making the treatment available to those who cannot afford it.